XSHG600624
Market cap614mUSD
Jan 09, Last price
6.63CNY
1D
-1.04%
1Q
83.15%
Jan 2017
-22.91%
Name
SHANGHAI FUDAN FORWARD S&T CO LTD
Chart & Performance
Profile
Shanghai Fudan Forward S&T Co., Ltd operates in software development, biomedicine, real estate, and other businesses. The company develops and exports software to Japan; and researches, develops, produces, and sells chemical drugs, Chinese patent medicines, freeze-dried powder injections, and solid preparations. It is also involved in the development of high-tech parks; and development, production, and sale of uninterruptible power supply and VRLA battery products, as well as professional agent of car audio brand. In addition, the company provides investment and consulting, and venture capital investment solutions. Shanghai Fudan Forward S&T Co., Ltd was founded in 1984 and is based in Shanghai, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 679,679 -13.86% | 789,005 -24.23% | |||||||
Cost of revenue | 585,337 | 698,658 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 94,342 | 90,348 | |||||||
NOPBT Margin | 13.88% | 11.45% | |||||||
Operating Taxes | 16,686 | 3,263 | |||||||
Tax Rate | 17.69% | 3.61% | |||||||
NOPAT | 77,656 | 87,085 | |||||||
Net income | 5,963 805.14% | 659 | |||||||
Dividends | (17,976) | ||||||||
Dividend yield | 0.48% | ||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 490,959 | 374,352 | |||||||
Long-term debt | 46,704 | 172,694 | |||||||
Deferred revenue | 72,769 | 77,117 | |||||||
Other long-term liabilities | 64,053 | 60,635 | |||||||
Net debt | 193,917 | 30,999 | |||||||
Cash flow | |||||||||
Cash from operating activities | 7,034 | 28,146 | |||||||
CAPEX | (7,508) | ||||||||
Cash from investing activities | 59,417 | ||||||||
Cash from financing activities | (69,858) | ||||||||
FCF | 200,068 | 80,002 | |||||||
Balance | |||||||||
Cash | 305,482 | 309,179 | |||||||
Long term investments | 38,264 | 206,868 | |||||||
Excess cash | 309,763 | 476,597 | |||||||
Stockholders' equity | 723,772 | 872,000 | |||||||
Invested Capital | 1,189,221 | 1,147,637 | |||||||
ROIC | 6.65% | 7.59% | |||||||
ROCE | 6.28% | 5.56% | |||||||
EV | |||||||||
Common stock shares outstanding | 662,550 | 679,347 | |||||||
Price | 5.71 -0.17% | 5.72 -17.46% | |||||||
Market cap | 3,783,162 -2.64% | 3,885,865 -17.96% | |||||||
EV | 4,017,779 | 4,028,188 | |||||||
EBITDA | 149,438 | 128,026 | |||||||
EV/EBITDA | 26.89 | 31.46 | |||||||
Interest | 20,335 | 21,594 | |||||||
Interest/NOPBT | 21.55% | 23.90% |